2013
DOI: 10.1016/j.toxlet.2013.03.019
|View full text |Cite
|
Sign up to set email alerts
|

Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
34
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 40 publications
(35 citation statements)
references
References 41 publications
(40 reference statements)
1
34
0
Order By: Relevance
“…Our previous studies have demonstrated the prominent effect of arsenic trioxide (ATO) in inhibiting the stemness of glioma stem cells (GSCs) by downregulating Notch signaling [7,8]. Raddeanin A (RA), an active extraction from the root of the traditional Chinese medicinal herb Anemone raddeana Regel [9], plays an important role in suppressing tumors (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Our previous studies have demonstrated the prominent effect of arsenic trioxide (ATO) in inhibiting the stemness of glioma stem cells (GSCs) by downregulating Notch signaling [7,8]. Raddeanin A (RA), an active extraction from the root of the traditional Chinese medicinal herb Anemone raddeana Regel [9], plays an important role in suppressing tumors (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Jianing Wu identified new therapeutic strategy for cancer stem-like cells and one of the mechanisms was that As 2 O 3 inhibited tumor proliferation through reducing the phosphorylation of AKT [32]. Ho-Shin Gwak studied the role of arsenic hexoxide (As 4 O 6 ) in inhibiting proliferation of glioblastoma cells, and they observed that As 4 O 6 decreased Akt phosphorylation in a dose-dependent manner in all malignant glioma cell lines used in the experiment [33].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, arsenic trioxide (ATO) is an FDA-approved drug used for treatment of patients with acute promyelocytic leukemia (APL). Preclinical studies have confirmed that ATO can induce cell apoptosis and inhibit tumor cell proliferation in a wide variety of solid tumors [32]. Therefore, it is very meaningful to investigate the involved mechanisms of arsenic toxicity.…”
Section: Discussionmentioning
confidence: 99%